With a growing customer base in North America, Rarity Bioscience has now established a subsidiary, Rarity Bioscience Inc., incorporated in Delaware, USA — a key step in strengthening our international operations and supporting our North American customers and partners.
This marks an important milestone in Rarity Bioscience’s international expansion and will serve as a strategic platform to streamline operations, enhance customer support, and expand commercial reach across North America. This local presence will enable faster and more direct access to Rarity Bioscience’s products, developed to deliver unprecedented sensitivity and precision in molecular analysis.
Over the past years, Rarity Bioscience has experienced remarkable growth, driven by innovation, dedication, and a clear vision for the future of molecular diagnostics. The establishment of Rarity Bioscience Inc. marks a natural next step in our mission to make superRCA® technology more widely available and to further our goal of democratizing mutation detection worldwide.
Photo by NASA
